Veru (VERU) to Release Earnings on Thursday
Veru (VERU) to Release Earnings on Thursday
Veru (NASDAQ:VERU – Get Rating) will release its earnings data before the market opens on Thursday, February 9th. Analysts expect Veru to post earnings of ($0.38) per share for the quarter. Persons that are interested in registering for the company's earnings conference call can do so using this link.
威魯 (NASDAQ: VERU — 獲取評級) 將在 2 月 9 日(星期四)市場開盤之前發布其收益數據。分析師預計維魯將在本季度發布每股收益(0.38 美元)。有興趣註冊該公司的盈利電話會議的人可以使用此鏈接這樣做。
Veru (NASDAQ:VERU – Get Rating) last posted its quarterly earnings data on Monday, December 5th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.29) by ($0.22). The firm had revenue of $2.59 million for the quarter, compared to analysts' expectations of $11.51 million. Veru had a negative net margin of 212.88% and a negative return on equity of 69.57%. On average, analysts expect Veru to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
威魯 (NASDAQ: VERU-獲取評級) 上次發布其季度收益數據週一, 12 月 5 日.該公司報告了本季每股盈利(0.51 美元),缺少分析師的共識估計(0.29 美元)為(0.22 美元)。該公司本季度的收入為 259 萬美元,而分析師的預期為 1151 萬美元。維魯的負淨利潤率為 212.88%,負資產回報率為 69.57%。平均而言,分析師預計 Vuru 將在當前會計年度公佈 -1 美元每股盈利,下一個會計年度每股收益為 -1 美元。
Veru Stock Up 2.4 %
真正的股票上漲 2.4%
VERU opened at $5.90 on Thursday. The firm has a market capitalization of $475.66 million, a P/E ratio of -5.62 and a beta of -0.27. The firm's 50 day moving average is $5.57 and its 200-day moving average is $10.26. Veru has a 52-week low of $4.34 and a 52-week high of $24.55.
維魯星期四以 5.90 美元開業。該公司的市值為 475.66 億美元,市盈率為 -5.62,測試值為 -0.27。該公司的 50 日移動平均線為 5.57 美元,其 200 天移動平均線為 10.26 美元。維魯擁有 52 周低點 4.34 美元,52 周高點為 24.55 美元。
Institutional Trading of Veru
維魯的機構交易
Analyst Ratings Changes
分析師等級變更
Separately, HC Wainwright dropped their price objective on shares of Veru from $21.00 to $18.00 and set a "buy" rating on the stock in a research note on Wednesday, December 7th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has an average rating of "Buy" and a consensus price target of $33.50.
另外,韋賴特(HC Wainwright)將維魯股票的價格目標從 21.00 美元降至 18.00 美元,並在 12 月 7 日(星期三)的研究報告中設定了該股票的「買入」評級。五位股票研究分析師對該股票進行了買入評級進行了評級,根據 MarketBeat 的說法,該股票目前的平均評級為「買入」,共識價格目標為 33.50 美元。
About Veru
關於維魯
(Get Rating)
(取得評分)
Veru, Inc is an oncology biopharmaceutical company, which engages in developing novel medicines for the management of prostate cancer and breast cancer. Its prostate cancer drug candidates include: VERU-111, an oral alpha and beta tubulin inhibitor, which is in a Phase 2 clinical trial for the treatment of metastatic castration and androgen receptor targeting agent resistant prostate cancer, VERU-100, a novel, proprietary, GnRH antagonist peptide drug formulation designed to address the current limitations of commercially available androgen deprivation therapies (ADT) for advanced prostate cancer, and Zuclomiphene Citrate, an oral nonsteroidal estrogen receptor agonist being developed to treat hot flashes, a common side effect caused by ADT.
Vuru, Inc 是一家腫瘤生物製藥公司,致力於開發用於治療前列腺癌和乳腺癌的新型藥物。其前列腺癌候選藥物包括:VERU-111,口服 α 和 β 小管素抑製劑,這是在 2 期臨床試驗中,用於治療轉移性閹割和雄激素受體標靶劑抗性前列腺癌,VERU-100,一種新穎,專有,GnRH 拮抗劑肽藥物配方,旨在解決市售的雄激素剝奪療法(ADT)用於治療前列腺癌的當前局限性(ADT)用於晚期前列腺癌,治療前列腺癌,檸檬酸正在開發用於治療潮熱的口服非類固醇雌激素受體激動劑, 和ADT 引起的常見副作用。
Featured Stories
特色故事
- Get a free copy of the StockNews.com research report on Veru (VERU)
- Bed Bath & Beyond Is Circling the Drain
- Allegro Microsystems Is A Well-Positioned Semiconductor Stock
- Scotts Miracle-Gro Hits Bottom, Reversal In Play
- Altria is a Great Recession Stock, Long-Term Outlook Uncertain
- Novavax Shares Jumped in January While Others Slipped
- 獲取有關維魯研究報告的免費副本
- 床浴 & 超越是盤旋排水
- Allegro 微系統是定位良好的半導體股票
- 斯科茨奇蹟-格羅擊中底部,反轉在遊戲中
- 阿爾特里亞是一個巨大的經濟衰退股票,長期前景不確定
- 諾瓦克斯股價在 1 月份跳漲,而其他股票則下滑
Receive News & Ratings for Veru Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veru and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Vuru 日報的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Vuru 和相關公司的最新新聞和分析師評級的簡要每日摘要。